acetoxyacetylaminofluorene has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, MT; Lin-Lee, YC; Liu, Z; Mills, GB; Tatebe, S; Unate, H; Wei, Y | 1 |
1 other study(ies) available for acetoxyacetylaminofluorene and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling.
Topics: 2-Acetylaminofluorene; Acetoxyacetylaminofluorene; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line; Drug Resistance, Multiple; Electrophoretic Mobility Shift Assay; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; NADPH Oxidases; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; rac GTP-Binding Proteins; RNA, Messenger; Signal Transduction; Superoxides; Tumor Cells, Cultured; Up-Regulation | 2002 |